Fig. 1From: A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer preventionPercentage of serous cancer patients and endometrial and clear cell patients seen at HCP annuallyBack to article page